Coriolis Pharma offers analytical ultracentrifugation, or AUC for short, for biological and virus-based drugs from the early development phase through to post-market surveillance. Coriolis is currently preparing for inspection by the relevant regulatory authority in order to obtain the certificate for the provision of...
The Board of Directors of Sandoz announced that it will nominate Mathai Mammen, M.D., Ph.D., and Michael Rechsteiner for election to the Board at the Annual General Meeting on April 30, 2024. At the same time, Sandoz announced that Remco Steenbergen, currently a member of the Sandoz Board of Directors, will become a...
In 2018, potentially carcinogenic nitrosamine impurities were detected in several medicines. Since then, public awareness of the potential health risk of nitrosamines has increased significantly worldwide. To help reduce the risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals and dietary...
A strong Swiss franc as well as the decline in sales in the coronavirus business and strong competition from generic products have impacted Roche in 2023. In the past financial year, the pharmaceutical company recorded sales growth of one percent at constant exchange rates to CHF 58.7 billion. This increase in sales...
Novartis closed both the fourth quarter and the financial year in the new constellation of its continuing operations with solid growth in sales, operating income and profit. Net sales in the fourth quarter amounted to 11.4 billion dollars, an increase of eight percent. The result was characterized by volume increases...
As a globally active Contract Development and Manufacturing Organization (CDMO), Vetter has joined the German Association of Research-Based Pharmaceutical Companies vfa as an associate member. With this special membership, the vfa recognizes the significant role that the pharmaceutical service provider plays in the...
Gerresheimer and Aptar Digital Health, an expert in ‘software as a medical device’ (SaMD), digital patient support programs (PSPs) and disease management solutions, collaborate to develop an integrated solution for cancer therapy management. As part of this collaboration, the “Gx SensAir”-on-body drug delivery device...
Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company has secured a major client for the new Rentschler Biopharma Manufacturing Center (RBMC) facility at its manufacturing site in Milford, Massachusetts. The RBMC is planned to be...
Vetter has been a member of the Science Based Targets Initiative (SBTi) since November 2023. The aim of the companies in the SBTi is to become climate-neutral by 2050. The initiative thus represents the strictest climate protection targets for companies worldwide. The pharmaceutical service provider has thus committed...
The Swiss pharmaceutical company Novartis has presented the results for the third quarter of 2023. Thus, net sales increased by twelve percent to $11.8 billion. Net income is $1.5 billion, an increase of 14 percent. These are the first quarterly figures announced by the pharmaceutical company without its spun-off...
